Healthy Aging Through Dietary Intervention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2023-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To test the impact of flavanol supplementation of cardiac and vascular function and subsequently on exercise capacity in elderly individuals

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Dietary Nitrate on Age-related Vascular Function

NCT01729234

Endothelial Dysfunction

COMPLETED PHASE1/PHASE2

Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity

NCT00175968

Healthy

COMPLETED PHASE1

Histamines and Central Hemodynamics

NCT07285031

Histamine Exercise

RECRUITING NA

L-Citrulline and Endothelial Function

NCT05722860

Aging

RECRUITING PHASE1

Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People

NCT01734616

Regional Blood Flow

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging, Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Flavanol

500 mg of flavanols twice daily

Group Type EXPERIMENTAL

Flavanol

Intervention Type DRUG

Assessement, supplementation for 30 days with either Placebo or Flavanols, Re-assessment

Placebo

nutrient matched control capsule

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Assessement, supplementation placebo for 30 days with either Placebo or Flavanols, Re-assessment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Flavanol

Assessement, supplementation for 30 days with either Placebo or Flavanols, Re-assessment

Intervention Type DRUG

Placebo

Assessement, supplementation placebo for 30 days with either Placebo or Flavanols, Re-assessment

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 50-79

Exclusion Criteria

* non-cardiac limitations of exercise capacity such as orthopedic or neurological disorders, BMI \>35 kg/m2, active smoking, uncontrolled blood pressure, diabetes, COPD, atrial fibrillation, cardiomyopathy, coronary heart disease, valvular heart disease, cardiac pacemaker, acute respiratory tract infections, missing ability or missing cooperation to participate in the study

Minimum Eligible Age

50 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes